AELIX Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- AELIX Therapeutics's estimated annual revenue is currently $2M per year.
- AELIX Therapeutics's estimated revenue per employee is $155,000
Employee Data
- AELIX Therapeutics has 13 Employees.
- AELIX Therapeutics grew their employee count by -13% last year.
AELIX Therapeutics's People
| Name | Title | Email/Phone |
|---|
AELIX Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 50 | N/A | N/A | N/A |
#2 | $1.1M | 7 | N/A | N/A | N/A |
#3 | $7.1M | 46 | N/A | N/A | N/A |
#4 | $57.4M | 370 | 19% | N/A | N/A |
#5 | $11.5M | 74 | 10% | N/A | N/A |
#6 | $56.9M | 367 | 25% | N/A | N/A |
#7 | $2M | 13 | -13% | N/A | N/A |
#8 | $2.6M | 17 | -29% | N/A | N/A |
#9 | $5.1M | 33 | 22% | N/A | N/A |
#10 | $7M | 45 | 32% | N/A | N/A |
What Is AELIX Therapeutics?
AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Barcelona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 13 | 0% | N/A |
#2 | $2M | 13 | 30% | N/A |
#3 | $1.8M | 13 | N/A | N/A |
#4 | $2.1M | 14 | 8% | N/A |
#5 | $1.3M | 14 | -7% | N/A |